IYBFX
Price
$25.74
Change
-$0.15 (-0.58%)
Updated
Feb 3 closing price
Net Assets
1.99B
RLEFX
Price
$38.38
Change
-$0.55 (-1.41%)
Updated
Feb 3 closing price
Net Assets
269.72B
Interact to see
Advertisement

IYBFX vs RLEFX

Header iconIYBFX vs RLEFX Comparison
Open Charts IYBFX vs RLEFXBanner chart's image
Nomura Balanced Fund
Price$25.74
Change-$0.15 (-0.58%)
VolumeN/A
Net Assets1.99B
American Funds American Balanced R5E
Price$38.38
Change-$0.55 (-1.41%)
VolumeN/A
Net Assets269.72B
IYBFX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
IYBFX vs. RLEFX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IYBFX is a Buy and RLEFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 270B vs. IYBFX (1.99B). RLEFX pays higher dividends than IYBFX: RLEFX (2.06) vs IYBFX (0.81). IYBFX was incepted earlier than RLEFX: IYBFX (13 years) vs RLEFX (10 years). IYBFX (1.34) is less costly to investors than RLEFX (0.39). IYBFX is a more actively managed with annual turnover of: 76.00 vs. RLEFX (44.00). IYBFX has a lower initial minimum investment than RLEFX: IYBFX (0) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 11.56 vs. IYBFX (8.06). RLEFX return over 5 years is better than : 36.72 vs. IYBFX (1.23).
IYBFXRLEFXIYBFX / RLEFX
Total Expense Ratio1.230.39315%
Annual Report Gross Expense Ratio1.340.39344%
Fund Existence13 years10 years-
Gain YTD0.8622.48335%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.99B270B1%
Annual Yield % from dividends0.812.0640%
Returns for 1 year8.0611.5670%
Returns for 3 years39.6837.57106%
Returns for 5 years1.2336.723%
Returns for 10 years26.2390.6029%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAPY0.030.01
+40.00%
Adaptimmune Therapeutics plc
BOMXF2.05N/A
N/A
Bolsa Mexicana de Valores, S.A.B. de C.V.
FLUIF30.25N/A
N/A
Fluidra SA
PBCO18.16N/A
N/A
PBCO Financial Corporation
SVNDF14.83N/A
N/A
Seven & I Holdings Co., Ltd.